Daiichi Sankyo drops Japan levofloxacin patent case
This article was originally published in Scrip
Executive Summary
Daiichi Sankyo has decided not to pursue any further a case involving the extension of Japanese patents for its antibacterial Cravit (levofloxacin hydrate).